Literature DB >> 9708863

Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells.

D J Reis1, X C Yang, T A Milner.   

Abstract

We examined the cellular and subcellular localization of agmatine in the hippocampal CA1 region by immunocytochemistry. By light microscopy, agmatine-like immunoreactivity (agmatine-LI) was found primarily in the perikarya and dendritic profiles of pyramidal cells and in punctate processes preponderantly in stratum radiatum. Electron microscopy revealed that agmatine-LI was cytoplasmic and concentrated in 'clusters' associated with mitochondria and tubular vesicles. In stratum radiatum, agmatine-LI was primarily in axons and axon terminals associated with small, synaptic vesicles. The terminals almost exclusively formed asymmetric synapses on the spines of dendrites, many of which originated from pyramidal cells. Some agmatine-LI also was present in shafts and spines of pyramidal cell dendrites and in astrocytic processes. The results demonstrate that agmatine in the hippocampus is found primarily in terminals forming excitatory (asymmetric) synapses on pyramidal cells, some of which contain agmatine-LI. These findings further implicate agmatine as an endogenous neurotransmitter which may be co-stored with L-glutamate and may act in part in the rat hippocampus as a blocker of the N-methyl-D-aspartate receptor and nitric oxide synthase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708863     DOI: 10.1016/s0304-3940(98)00466-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons.

Authors:  M-Y Zhu; W-P Wang; G Bissette
Journal:  Neuroscience       Date:  2006-06-13       Impact factor: 3.590

3.  Agmatine attenuates stress- and lipopolysaccharide-induced fever in rats.

Authors:  Feyza Aricioglu; Soundar Regunathan
Journal:  Physiol Behav       Date:  2005-06-30

4.  Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

Authors:  C A Fairbanks; K L Schreiber; K L Brewer; C G Yu; L S Stone; K F Kitto; H O Nguyen; B M Grocholski; D W Shoeman; L J Kehl; S Regunathan; D J Reis; R P Yezierski; G L Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

5.  Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects.

Authors:  Yangzheng Feng; Michael H LeBlanc; Soundar Regunathan
Journal:  Neurosci Lett       Date:  2005-08-24       Impact factor: 3.046

6.  Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels.

Authors:  Meng-Yang Zhu; Wei-Ping Wang; Jingjing Huang; Soundar Regunathan
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

7.  Cardiovascular effects of agmatine within the rostral ventrolateral medulla are similar to those of clonidine in anesthetized rats.

Authors:  Jun Yang; Wei-Zhong Wang; Fu-Ming Shen; Ding-Feng Su
Journal:  Exp Brain Res       Date:  2004-10-05       Impact factor: 1.972

8.  Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine.

Authors:  Meng-Yang Zhu; Abiye Iyo; John E Piletz; Soundar Regunathan
Journal:  Biochim Biophys Acta       Date:  2004-01-22

Review 9.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons.

Authors:  Wei-Ping Wang; Abiye H Iyo; Javier Miguel-Hidalgo; Soundar Regunathan; Meng-Yang Zhu
Journal:  Brain Res       Date:  2006-03-20       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.